Insufficient scRNA-seq data for expression of OPN5 at single-cell level.
Insufficient scRNA-seq data for expression of OPN5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 76% | 5.85 | 2005 / 2642 | 0% | 0.01 | 2 / 705 |
| heart | 74% | 24.08 | 641 / 861 | 0% | 0 | 0 / 0 |
| stomach | 53% | 2.48 | 189 / 359 | 1% | 0.01 | 2 / 286 |
| muscle | 51% | 2.63 | 406 / 803 | 0% | 0 | 0 / 0 |
| kidney | 48% | 2.96 | 43 / 89 | 0% | 0.00 | 1 / 901 |
| thymus | 45% | 1.85 | 292 / 653 | 0% | 0.01 | 1 / 605 |
| skin | 40% | 1.87 | 715 / 1809 | 0% | 0.00 | 1 / 472 |
| prostate | 34% | 1.76 | 84 / 245 | 0% | 0 | 0 / 502 |
| lung | 32% | 1.17 | 185 / 578 | 0% | 0.00 | 2 / 1155 |
| blood vessel | 32% | 1.09 | 428 / 1335 | 0% | 0 | 0 / 0 |
| uterus | 31% | 1.01 | 52 / 170 | 0% | 0.00 | 1 / 459 |
| breast | 27% | 1.15 | 125 / 459 | 0% | 0.00 | 1 / 1118 |
| adipose | 27% | 0.95 | 327 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 25% | 1.08 | 60 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 25% | 0.76 | 64 / 258 | 0% | 0 | 0 / 230 |
| esophagus | 24% | 0.86 | 352 / 1445 | 0% | 0 | 0 / 183 |
| ovary | 23% | 0.79 | 42 / 180 | 0% | 0 | 0 / 430 |
| bladder | 19% | 0.48 | 4 / 21 | 0% | 0 | 0 / 504 |
| intestine | 16% | 0.45 | 156 / 966 | 0% | 0 | 0 / 527 |
| liver | 13% | 0.41 | 29 / 226 | 0% | 0 | 0 / 406 |
| pancreas | 12% | 0.35 | 40 / 328 | 0% | 0 | 0 / 178 |
| peripheral blood | 7% | 0.17 | 64 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007601 | Biological process | visual perception |
| GO_0007604 | Biological process | phototransduction, UV |
| GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0009584 | Biological process | detection of visible light |
| GO_0007602 | Biological process | phototransduction |
| GO_0071482 | Biological process | cellular response to light stimulus |
| GO_0071492 | Biological process | cellular response to UV-A |
| GO_1990384 | Biological process | hyaloid vascular plexus regression |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008020 | Molecular function | G protein-coupled photoreceptor activity |
| GO_0005502 | Molecular function | 11-cis retinal binding |
| Gene name | OPN5 |
| Protein name | Opsin 5 Opsin-5 (G-protein coupled receptor 136) (G-protein coupled receptor PGR12) (Neuropsin) (Transmembrane protein 13) |
| Synonyms | TMEM13 PGR12 hCG_1642475 GPR136 |
| Description | FUNCTION: G-protein coupled receptor which selectively activates G(i) type G proteins via ultraviolet A (UVA) light-mediated activation in the retina (By similarity). Preferentially binds the chromophore 11-cis retinal and is a bistable protein that displays emission peaks at 380 nm (UVA light) and 470 nm (blue light) . Required for the light-response in the inner plexiform layer, and contributes to the regulation of the light-response in the nerve fiber layer, via phosphorylated DAT/SLC6A3 dopamine uptake (By similarity). Involved in local corneal and retinal circadian rhythm photoentrainment via modulation of the UVA light-induced phase-shift of the retina clock (By similarity). Acts as a circadian photoreceptor in the outer ear, via modulation of circadian clock-gene expression in response to violet light during the light-to-dark transition phase and night phase of the circadian cycle (By similarity). Required in the retina to negatively regulate hyaloid vessel regression during postnatal development via light-dependent OPN5-SLC32A1-DRD2-VEGFR2 signaling (By similarity). Involved in the light-dependent regulation of retina and vitreous compartment dopamine levels (By similarity). . |
| Accessions | ENST00000393699.2 ENST00000371211.7 J3KPQ2 Q6U736 ENST00000489301.6 D6RDV4 |